992 / 1084
Recent
advancements in genomic
technology have now allowed
GCs to be
studied at high resolution and at the molecular
level
Such
molecular profiling data
have greatly
facilitated
identification of candidate driver
alterations in GC
Achieving an understanding of potential driver
alterations involved in GC pathogenesis can
lead to the
identification of
clinically important
biomarkers and
potential treatment targets
03/28/2017